文献速递胸部肿瘤

维生素与生活方式(VITAL)队列中长期补充一碳代谢相关B族维生素与肺癌风险的关系

Long-Term, Supplemental, One-Carbon Metabolism-Related Vitamin B Use in Relation to Lung Cancer Risk in the Vitamins and Lifestyle (VITAL) Cohort.
PubMed 文献 · J Clin Oncol · 2017-08-22

在VITAL队列77,118名50至76岁参与者中,前瞻性链接癌症登记处确定808例侵袭性肺癌;女性补充维生素B6、叶酸和B12与肺癌风险无关,男性从单一补充剂(而非复合维生素)来源使用B6和B12与风险增加30%至40%相关,最高剂量组风险几乎翻倍,吸烟者中风险更高。

要点

  • 男性从单一补充剂来源使用维生素B6和B12与肺癌风险增加30%至40%相关。
  • 男性最高剂量组维生素B6(>20 mg/d)HR 1.82(95%CI 1.25至2.65),B12(>55µg/d)HR 1.98(95%CI 1.32至2.97)。
  • 女性补充维生素B6、叶酸和B12与肺癌风险无关。

核心结论

  • 这种性别和来源特异性的关联进一步表明,补充B族维生素对肺癌无化学预防作用,且可能有害。

研究设计与样本

  • VITAL队列研究,2000年10月至2002年12月招募77,118名50至76岁参与者,前瞻性链接基于人群的癌症登记处确定808例新发原发性侵袭性肺癌。

主要发现

  • 女性补充维生素B6、叶酸和B12与肺癌风险无关。
  • 男性从单一补充剂来源(而非复合维生素)使用维生素B6和B12与肺癌风险增加30%至40%相关。
  • 与未使用者相比,男性10年平均补充剂量最高组维生素B6(>20 mg/d)HR 1.82(95%CI 1.25至2.65),B12(>55µg/d)HR 1.98(95%CI 1.32至2.97)。
  • 对于维生素B6和B12,基线吸烟的男性中风险更高。
  • 除腺癌(与吸烟关系较小的类型)外,B6和B12关联在所有组织学类型中均明显。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Purpose Inconsistent findings have been reported of a link between the use of one-carbon metabolism-related B vitamins and lung cancer risk. Because of the high prevalence of supplemental vitamin B use, any possible increased association warrants further investigation. We examined the association between long-term use of supplemental B vitamins on the one-carbon metabolism pathway and lung cancer risk in the Vitamins and Lifestyle (VITAL) cohort, which was designed specifically to look at supplement use relative to cancer risk. Methods A total of 77,118 participants of the VITAL cohort, 50 to 76 years of age, were recruited between October 2000 and December 2002 and included in this analysis. Incident, primary, invasive lung cancers (n = 808) were ascertained by prospectively linking the participants to a population-based cancer registry. The 10-year average daily dose from individual and multivitamin supplements were the exposures of primary interest. Results Use of supplemental vitamins B6, folate, and B12 was not associated with lung cancer risk among women. In contrast, use of vitamin B6 and B12 from individual supplement sources, but not from multivitamins, was associated with a 30% to 40% increase in lung cancer risk among men. When the 10-year average supplement dose was evaluated, there was an almost two-fold increase in lung cancer risk among men in the highest categories of vitamin B6 (> 20 mg/d; hazard ratio, 1.82; 95% CI, 1.25 to 2.65) and B12 (> 55µg/d; hazard ratio, 1.98; 95% CI, 1.32 to 2.97) compared with nonusers. For vitamin B6 and B12, the risk was even higher among men who were smoking at baseline. In addition, the B6 and B12 associations were apparent in all histologic types except adenocarcinoma, which is the type less related to smoking. Conclusion This sex- and source-specific association provides further evidence that vitamin B supplements are not chemopreventive for lung cancer and may be harmful.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Brasky TM, White E, Chen CL, et al. Long-Term, Supplemental, One-Carbon Metabolism-Related Vitamin B Use in Relation to Lung Cancer Risk in the Vitamins and Lifestyle (VITAL) Cohort. J Clin Oncol. 2017. PMID: 28829668. doi:10.1200/JCO.2017.72.7735

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。